Jump to main content
Jump to site search


A Β-glucuronidase-responsive albumin-binding prodrug programmed for the double release of monomethylauristatin E

Abstract

We report on the synthesis, in vitro and in vivo biological evaluations of a dimeric Β-glucuronidase-responsive albumin-binding prodrug designed for the double release of MMAE upon a single enzymatic activation step. This prodrug produced a significant antitumour activity in mice bearing subcutaneous LS174T colorectal adenocarcinoma xenografts without inducing side effects.

Back to tab navigation

Supplementary files

Publication details

The article was received on 14 Sep 2018, accepted on 25 Oct 2018 and first published on 26 Oct 2018


Article type: Research Article
DOI: 10.1039/C8MD00466H
Citation: Med. Chem. Commun., 2018, Accepted Manuscript
  •   Request permissions

    A Β-glucuronidase-responsive albumin-binding prodrug programmed for the double release of monomethylauristatin E

    B. Renoux, L. Fangous, C. Hötten, E. Peraudeau, B. Eddhif, P. Poinot, J. Clarhaut and S. Papot, Med. Chem. Commun., 2018, Accepted Manuscript , DOI: 10.1039/C8MD00466H

Search articles by author

Spotlight

Advertisements